These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3558987

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG, McGovern B, Schoenfeld MH, Garan H, Newell JB, McElroy M, Ruskin JN.
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [Abstract] [Full Text] [Related]

  • 26. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE, Werner JA, Bardy GH, Graham EL, Pulaski WP, Fahrenbruch CE, Greene HL.
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [Abstract] [Full Text] [Related]

  • 27. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB, Waxman HL, Buxton AE, Josephson ME.
    Am J Cardiol; 1983 Mar 01; 51(5):759-64. PubMed ID: 6829435
    [Abstract] [Full Text] [Related]

  • 28. Effect of procainamide on induced ventricular tachycardia.
    Engel TR, del Gonzalez A, Meister SG, Franki WS.
    Clin Pharmacol Ther; 1978 Sep 01; 24(3):274-82. PubMed ID: 688720
    [Abstract] [Full Text] [Related]

  • 29. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Forester D.
    Chest; 1979 Jun 01; 75(6):745. PubMed ID: 436537
    [No Abstract] [Full Text] [Related]

  • 30. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS, Gang ES, Rosenthal ME, Mandel WJ, Peter T.
    Am J Cardiol; 1985 Nov 15; 56(13):883-6. PubMed ID: 3904387
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY, Benowitz NL.
    Drug Saf; 1990 Nov 15; 5(6):393-420. PubMed ID: 2285495
    [Abstract] [Full Text] [Related]

  • 34. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
    Denniss AR, Ross DL, Richards DA, Cody DV, Russell PA, Young AA, Uther JB.
    Am J Cardiol; 1986 Aug 01; 58(3):261-5. PubMed ID: 3739914
    [Abstract] [Full Text] [Related]

  • 35. Suppression of refractory recurrent ventricular tachycardia by transvenous rapid cardiac pacing and antiarrhythmic drugs. Report of seven cases.
    Friedberg CK, Lyon LJ, Donoso E.
    Am Heart J; 1970 Jan 01; 79(1):44-50. PubMed ID: 5410281
    [No Abstract] [Full Text] [Related]

  • 36. Quinidine pharmacodynamics in patients with arrhythmia: effects of left ventricular function.
    Gillis AM, Mitchell LB, Wyse DG, McDonald M, Duff HJ.
    J Am Coll Cardiol; 1995 Apr 01; 25(5):989-94. PubMed ID: 7897143
    [Abstract] [Full Text] [Related]

  • 37. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
    DiMarco JP, Garan H, Ruskin JN.
    Am J Cardiol; 1983 Jan 01; 51(1):90-5. PubMed ID: 6849270
    [Abstract] [Full Text] [Related]

  • 38. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
    Duff HJ, Wyse DG, Manyari D, Mitchell LB.
    Am J Cardiol; 1985 Jan 01; 55(1):92-7. PubMed ID: 3966404
    [Abstract] [Full Text] [Related]

  • 39. Analysis of antiarrhythmic drug concentrations determined during electrophysiologic drug testing in patients with inducible tachycardias.
    Berry NS, Bauman JL, Gallastegui JL, Bauma W, Beckman KJ, Hariman RJ.
    Am J Cardiol; 1988 Apr 15; 61(11):922-4. PubMed ID: 3354470
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.
    Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.